A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...

USC has received a $6m grant from the California Institute for Regenerative Medicine (CIRM) to advance a new gene therapy for ...

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England. About 50 people a year with the inherited blood disorder are likely ...